Timolol
Back to searchMolecule Structure
Scientific Name
Timolol
Description of the Drug
Timolol is a non-selective beta adrenergic blocker used in the treatment of elevated intraocular pressure in ocular hypertension or open angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00373
http://www.drugbank.ca/drugs/DB00373
Brand Name(s)
Betim, Betimol, Blocadren, Glaucol, Glau-opt, Nyogel, Timolol, Timoptic, Tiopex
Company Owner(s)
Thea Pharma Inc, Pacific Pharma, Watson Laboratories Inc, Bausch And Lomb Pharmaceuticals Inc, Merck And Co Inc, Mankind Pharma Ltd, Mylan Pharmaceuticals Inc, Akorn Operating Co Llc, Indoco Remedies Ltd, Micro Labs Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
| Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4912 | ||||||
| PharmGKB | PA451690 | ||||||
| DrugBank | DB00373 | ||||||
| PubChem: Thomson Pharma | 14899130 | 14825948 | |||||
| PubChem | 33624 | ||||||
| LINCS | LSM-2176 | ||||||
| Nikkaji | J10.426D | ||||||
| PDBe | TIM | ||||||
| BindingDB | 50292219 | ||||||
| EPA CompTox Dashboard | DTXSID4023674 | ||||||
| DrugCentral | 4061 | ||||||
| Brenda | 156335 | ||||||
| ChemicalBook | CB3266706 | ||||||
| Guide to Pharmacology | 565 | ||||||
| rxnorm | ISTALOL | TIMOLOL ANHYDROUS | TIMOLOL | TIMOLOL MALEATE | TIMOLOL HEMIHYDRATE | TIMOPTIC | BETIMOL |
| KEGG Ligand | C07141 | ||||||
| ChEBI | 9599 | ||||||
| ZINC | ZINC000000002176 |
